Pedictric Mrsa

Running head: PEDIATRIC COMMUNITY ACQUIRED MRSA









Community Acquired MRSA in Pediatrics
Research Critique Paper
Master’s Research; Liberty University


















Abstract
The epidemiology of community-acquired methicillin resistant staphylococcus aureus (CA-MRSA) within the pediatric population is increasing, as evidenced by the high prevalence of cases in several U.S. communities.   A prospective cross-sectional as well as a   retrospective study were performed, both of which   supported strong data of an alarming increase of CA-MRSA colonization in healthy children with no predisposing risk factor, compared to three to four year old records of CA-MRSA cases in children. A recent study in several large inner city clinics cultured healthy pediatrics of all ages yielded that 9.2 were colonized with MRSA. It’s a significant increase from a 2001 study (0.8%; P < 0.001).   Typically, colonization proceeds infection. Researchers are studying major factors in the emergence of the prevalent incline of CA-MRSA in healthy children with no predisposing risk factors (Creech, 2005; Dietrich, 2004; Frank, 1999; Herold, 1998; & Hussain, 2001).











Community Acquired MRSA in Pediatrics
Some staphylococcal bacteria are resistant to antibiotics and new, multiple stains of S. aureus have been discovered.   Methicillin-Resistant Staphylococcus aureus (MRSA) is a type of staph that is resistant to antibiotics called beta-lactams. Beta-lactam antibiotics include methicillin and other more common antibiotics such as oxacillin, penicillin and amoxicillin.   This bacterium is commonly carried on the skin or in the nose of healthy people; the bacteria are present, but not necessarily causing an infection.   This is typically the case in adults, not in the pediatric population.
Community-acquired methicillin resistant staphylococcus aureus (CA-MRSA), typically, in pediatrics occurred primarily with recognized predisposition risk....